Clinical Trial Update: Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating adjuvant therapy with apatinib for hepatocellular carcinoma patients with portal vein tumor thrombus after radical resect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: UNKNOWN